Your browser doesn't support javascript.
loading
High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.
Cleven, Arjen H G; Nardi, Valentina; Ok, Chi Young; Goswami, Maitrayee; Dal Cin, Paola; Zheng, Zongli; Iafrate, A John; Abdul Hamid, Myrurgia A; Wang, Sa A; Hasserjian, Robert P.
Afiliação
  • Cleven AH; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
  • Nardi V; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Ok CY; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Goswami M; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dal Cin P; Center of Advanced Molecular Diagnostics, Brigham & Women's Hospital, Boston, MA, USA.
  • Zheng Z; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Abdul Hamid MA; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Wang SA; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Mod Pathol ; 28(4): 552-63, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25412846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Proteína Supressora de Tumor p53 / Segunda Neoplasia Primária Idioma: En Ano de publicação: 2015 Tipo de documento: Article